Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OSIMERTINIB Cause Complication associated with device? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Complication associated with device have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.0% of all adverse event reports for OSIMERTINIB.

5
Reports of Complication associated with device with OSIMERTINIB
0.0%
of all OSIMERTINIB reports
0
Deaths
4
Hospitalizations

How Dangerous Is Complication associated with device From OSIMERTINIB?

Of the 5 reports, 4 (80.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.

Is Complication associated with device Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does OSIMERTINIB Cause?

Death (10,423) Malignant neoplasm progression (2,920) Diarrhoea (1,408) Drug resistance (1,026) Fatigue (819) Rash (772) Decreased appetite (706) Drug ineffective (627) Dyspnoea (621) Nausea (610)

What Other Drugs Cause Complication associated with device?

ETONOGESTREL (6,047) COPPER (1,083) BACLOFEN (525) TREPROSTINIL (422) EPOPROSTENOL (399) LEVONORGESTREL (344) ADALIMUMAB (269) CARBIDOPA\LEVODOPA (169) MACITENTAN (169) TEDUGLUTIDE (133)

Which OSIMERTINIB Alternatives Have Lower Complication associated with device Risk?

OSIMERTINIB vs OSPEMIFENE OSIMERTINIB vs OSPHENA OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB OSIMERTINIB vs OXACILLIN OSIMERTINIB vs OXALIPLATIN

Related Pages

OSIMERTINIB Full Profile All Complication associated with device Reports All Drugs Causing Complication associated with device OSIMERTINIB Demographics